These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Effect of timing of granulocyte-colony stimulating factor administration on leukopenia induced by systemic chemotherapy in patients with non-small-cell lung cancer--multi-center randomized crossover study]. Katakami N; Hasegawa T; Umeda B; Adachi S; Ishii N; Takada Y; Tsubota N; Nakano K; Tamura R; Nakai H Nihon Kyobu Shikkan Gakkai Zasshi; 1996 May; 34(5):520-8. PubMed ID: 8753109 [TBL] [Abstract][Full Text] [Related]
6. Comparison of two strategies for the treatment of radiogenic leukopenia using granulocyte colony stimulating factor. Adamietz IA; Rosskopf B; Dapper FD; von Lieven H; Boettcher HD Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):61-7. PubMed ID: 8641928 [TBL] [Abstract][Full Text] [Related]
7. [Appropriate administration of granulocyte colony stimulating factor for malignant lymphoma of the head and neck]. Miyaguchi M; Takeda J; Furuta H; Uozumi N; Miyabe K; Sakai S Nihon Jibiinkoka Gakkai Kaiho; 1993 Jul; 96(7):1099-104. PubMed ID: 7690070 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphoma: a pilot study for a leukocyte count oriented regimen. Sawada KI; Sato N; Kohno M; Hannda H; Yasukouchi T; Tanngo M; Hirayama A; Koike T Leuk Lymphoma; 1995 Dec; 20(1-2):103-9. PubMed ID: 8750630 [TBL] [Abstract][Full Text] [Related]
9. Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support. de Wit R; Verweij J; Bontenbal M; Kruit WH; Seynaeve C; Schmitz PI; Stoter G J Natl Cancer Inst; 1996 Oct; 88(19):1393-8. PubMed ID: 8827017 [TBL] [Abstract][Full Text] [Related]
10. Impact of colony-stimulating factor therapy on clinical outcome and frequency rate of nosocomial infections in intensive care unit neutropenic patients. Gruson D; Hilbert G; Vargas F; Valentino R; Chene G; Boiron JM; Reiffers J; Gbikpi-Benissan G; Cardinaud JP Crit Care Med; 2000 Sep; 28(9):3155-60. PubMed ID: 11008974 [TBL] [Abstract][Full Text] [Related]
11. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report]. Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674 [TBL] [Abstract][Full Text] [Related]
12. [Effect of granulocyte colony stimulating factor (G-CSF) on peripheral blood leukocytes and lymphocytes in patients with chemotherapy-induced leukopenia]. Böhme M; Schmidt D; Radke J; Morenz J; Weise W Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):670-4. PubMed ID: 7531660 [TBL] [Abstract][Full Text] [Related]
13. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455 [TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human granulocyte colony-stimulating factor in patients receiving chemotherapy for urogenital cancer. Urological rhG-CSF Study Group. Aso Y; Akaza H J Urol; 1992 Apr; 147(4):1060-4. PubMed ID: 1372661 [TBL] [Abstract][Full Text] [Related]
15. [Optimal way of administration of granulocyte colony stimulating factor in the treatment of urological cancer]. Okaneya T; Tsuruta T; Niwakawa M; Kawakami M; Kobayashi S; Ogawa A Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):680-5. PubMed ID: 7684099 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human granulocyte colony-stimulating factor after kidney transplantation: a retrospective analysis to evaluate the benefit or risk of immunostimulation. Schmaldienst S; Bekesi G; Deicher R; Franz M; Hörl WH; Pohanka E Transplantation; 2000 Feb; 69(4):527-31. PubMed ID: 10708106 [TBL] [Abstract][Full Text] [Related]
17. Randomized trial of sequential administration of G-CSF and GM-CSF vs. G-CSF alone following peripheral blood progenitor cell autograft in solid tumors. Recchia F; Accorsi P; Bonfini T; De Filippis S; Grimaldi M; Corrao G; Rosselli M; Amiconi G; Iacone A; Rea S J Interferon Cytokine Res; 2000 Feb; 20(2):171-7. PubMed ID: 10714552 [TBL] [Abstract][Full Text] [Related]
18. [Granulocyte colony-stimulating factor treatment (G-CSF) of antithyroid drug-induced granulocytopenia: granulocyte count measurement after 4 hours of G-CSF injection is useful for the detection of recovery from granulocytopenia]. Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N Nihon Naibunpi Gakkai Zasshi; 1994 Jun; 70(5):517-20. PubMed ID: 7525366 [TBL] [Abstract][Full Text] [Related]
19. [Feasibility of a cyclophosphamide methotrexate and 5-fluorouracil regime intravenously administered with and without granulocyte-colony stimulating factor in surgically treated breast carcinoma]. Garrone O; Del Mastro L; Mariani GL; Ardizzoni A; Venturini M; Rosso R Minerva Med; 1993 Sep; 84(9):467-72. PubMed ID: 7504219 [TBL] [Abstract][Full Text] [Related]
20. Whole blood harvested after granulocyte-colony stimulating factor (Neupogen) mobilization, and reinfused unprocessed after high-dose melphalan treatment, accelerates hematopoietic recovery in patients with multiple myeloma. Raina V; Sharma A; Kumar R; Bhargava M Cancer; 1996 Mar; 77(6):1073-8. PubMed ID: 8635126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]